111 related articles for article (PubMed ID: 38071190)
1. Anticancer role of lidocaine in oral squamous cell carcinoma through IGF2BP2-mediated CAV1 stability.
Wang Z; Zhang L; Wu T; Pan X; Li L; Liu Y
Oral Dis; 2023 Dec; ():. PubMed ID: 38071190
[TBL] [Abstract][Full Text] [Related]
2. m
Xu L; Li Q; Wang Y; Wang L; Guo Y; Yang R; Zhao N; Ge N; Wang Y; Guo C
Am J Cancer Res; 2021; 11(11):5282-5298. PubMed ID: 34873461
[TBL] [Abstract][Full Text] [Related]
3. N
Xu K; Dai X; Wu J; Wen K
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3375-3384. PubMed ID: 35763110
[TBL] [Abstract][Full Text] [Related]
4. IGF2BP2 acts as a m
Tang X; Tang Q; Li S; Li M; Yang T
Cell Death Discov; 2023 Oct; 9(1):371. PubMed ID: 37816718
[TBL] [Abstract][Full Text] [Related]
5. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
6. Lidocaine Inhibits Hepatocellular Carcinoma Development by Modulating circ_ITCH/miR-421/CPEB3 Axis.
Zhao L; Ma N; Liu G; Mao N; Chen F; Li J
Dig Dis Sci; 2021 Dec; 66(12):4384-4397. PubMed ID: 33433806
[TBL] [Abstract][Full Text] [Related]
7. IGF2BP2 inhibits invasion and migration of clear cell renal cell carcinoma via targeting Netrin-4 in an m
Wang G; Zhuang T; Zhen F; Zhang C; Wang Q; Miao X; Qi N; Yao R
Mol Carcinog; 2024 May; ():. PubMed ID: 38780170
[TBL] [Abstract][Full Text] [Related]
8. [Knockdown of IGF2BP2 inhibits colorectal cancer cell proliferation, migration and promotes tumor immunity by down-regulating MYC expression].
Liu T; Han C; Hu C; Mao S; Sun Y; Yang S; Yang K
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Apr; 39(4):303-310. PubMed ID: 37087547
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor 2 mRNA binding protein 2 regulates proliferation, migration, and angiogenesis of keratinocytes by modulating heparanase stability.
Zhi S; Li J; Kong X; Xie X; Zhang Q; Fang G
Bioengineered; 2021 Dec; 12(2):11267-11276. PubMed ID: 34753397
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
Tong S; Wang X; Guo X; Lu Z
J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162
[TBL] [Abstract][Full Text] [Related]
11. The m6A reader IGF2BP2 promotes the progression of esophageal squamous cell carcinoma cells by increasing the stability of OCT4 mRNA.
Zhao R; Li T; Zhao X; Yang Z; Ma L; Wang X
Biochem Cell Biol; 2024 Apr; 102(2):169-178. PubMed ID: 37917979
[TBL] [Abstract][Full Text] [Related]
12. Long Non-Coding RNA CCAT2 Promotes the Development of Esophageal Squamous Cell Carcinoma by Inhibiting miR-200b to Upregulate the IGF2BP2/TK1 Axis.
Wu X; Fan Y; Liu Y; Shen B; Lu H; Ma H
Front Oncol; 2021; 11():680642. PubMed ID: 34386421
[TBL] [Abstract][Full Text] [Related]
13. LINC00987 knockdown inhibits the progression of acute myeloid leukemia by suppressing IGF2BP2-mediated PA2G4 expression.
Liu C; Ma Y; Wang R; Su G
Anticancer Drugs; 2022 Jan; 33(1):e207-e217. PubMed ID: 34407052
[TBL] [Abstract][Full Text] [Related]
14. Tumor Suppressor microRNA-138 Suppresses Low-Grade Glioma Development and Metastasis via Regulating IGF2BP2.
Yang Y; Liu X; Cheng L; Li L; Wei Z; Wang Z; Han G; Wan X; Wang Z; Zhang J; Chen C
Onco Targets Ther; 2020; 13():2247-2260. PubMed ID: 32214825
[TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 promotes cancer progression via inhibiting ferroptosis in head and neck squamous cell carcinoma.
Lu T; Zhang Z; Pan X; Zhang J; Wang X; Wang M; Li H; Yan M; Chen W
J Oral Pathol Med; 2022 Jan; 51(1):52-62. PubMed ID: 34874578
[TBL] [Abstract][Full Text] [Related]
16. Lidocaine inhibits glioma cell proliferation, migration and invasion by modulating the circEZH2/miR-181b-5p pathway.
Wen J; Li X; Ding Y; Zheng S; Xiao Y
Neuroreport; 2021 Jan; 32(1):52-60. PubMed ID: 33252475
[TBL] [Abstract][Full Text] [Related]
17. Expression profile, clinical significance and biological functions of IGF2BP2 in esophageal squamous cell carcinoma.
Lu F; Chen W; Jiang T; Cheng C; Wang B; Lu Z; Huang G; Qiu J; Wei W; Yang M; Huang X
Exp Ther Med; 2022 Apr; 23(4):252. PubMed ID: 35261624
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA HOXC-AS1 exerts its oncogenic effects in esophageal squamous cell carcinoma by interaction with IGF2BP2 to stabilize SIRT1 expression.
Yang Z; Wan J; Ma L; Li Z; Yang R; Yang H; Li J; Zhou F; Ming L
J Clin Lab Anal; 2023 Jan; 37(1):e24801. PubMed ID: 36510377
[TBL] [Abstract][Full Text] [Related]
19. CircCDK1 blocking IGF2BP2-mediated m6A modification of CPPED1 promotes laryngeal squamous cell carcinoma metastasis via the PI3K/AKT signal pathway.
Li J; Cao H; Yang J; Wang B
Gene; 2023 Oct; 884():147686. PubMed ID: 37543219
[TBL] [Abstract][Full Text] [Related]
20. SUMOylation of IGF2BP2 promotes vasculogenic mimicry of glioma via regulating OIP5-AS1/miR-495-3p axis.
Li H; Wang D; Yi B; Cai H; Wang Y; Lou X; Xi Z; Li Z
Int J Biol Sci; 2021; 17(11):2912-2930. PubMed ID: 34345216
[No Abstract] [Full Text] [Related]
[Next] [New Search]
